Fedrilate
Chemical compound
- R05DB14 (WHO)
- 4-morpholin-4-ylbutan-2-yl 4-phenyloxane-4-carboxylate
- 23271-74-1
- 31796
- 29485 Y
- NT86R8M7J5
- D07389 Y
- ChEMBL2104591
- DTXSID70865087
- Interactive image
- O=C(OC(CCN1CCOCC1)C)C3(c2ccccc2)CCOCC3
InChI
- InChI=1S/C20H29NO4/c1-17(7-10-21-11-15-24-16-12-21)25-19(22)20(8-13-23-14-9-20)18-5-3-2-4-6-18/h2-6,17H,7-16H2,1H3 Y
- Key:RDEOYUSTRWNWLX-UHFFFAOYSA-N Y
Fedrilate is a centrally acting cough suppressant. It was patented as a mucolytic by UCB in 1971, but was never brought to market in the US.[1] In the Netherlands, it has been marketed as Tussefan and in combination with guaifenesin as Tussefan expectorans.[2]
References
- v
- t
- e
Cough and cold preparations (R05)
- Acetylcysteine#
- Ambroxol
- Bromhexine
- Carbocisteine
- Dembrexine hydrochloride
- Domiodol
- Dornase alfa
- Eprazinone
- Erdosteine
- Letosteine
- Mannitol
- Mesna
- Neltenexine
- Sobrerol
- Stepronin
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
This drug article relating to the respiratory system is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e